You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

MYLAN TECHNOLOGIES Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for MYLAN TECHNOLOGIES, and what generic and branded alternatives to MYLAN TECHNOLOGIES drugs are available?

MYLAN TECHNOLOGIES has thirteen approved drugs.



Summary for MYLAN TECHNOLOGIES

Drugs and US Patents for MYLAN TECHNOLOGIES

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Technologies ESTRADIOL estradiol FILM, EXTENDED RELEASE;TRANSDERMAL 075182-001 Feb 24, 2000 AB2 RX No No ⤷  Subscribe ⤷  Subscribe
Mylan Technologies NITROGLYCERIN nitroglycerin FILM, EXTENDED RELEASE;TRANSDERMAL 074559-001 Aug 30, 1996 AB2 RX No Yes ⤷  Subscribe ⤷  Subscribe
Mylan Technologies NITROGLYCERIN nitroglycerin FILM, EXTENDED RELEASE;TRANSDERMAL 074992-004 Nov 12, 1999 DISCN No No ⤷  Subscribe ⤷  Subscribe
Mylan Technologies FENTANYL-75 fentanyl FILM, EXTENDED RELEASE;TRANSDERMAL 076258-003 Jan 28, 2005 AB RX No No ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.